Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |